Experts Reflect on Oncology Advancements in 2017

Dec 29, 2017

Key opinion leaders share the biggest advancements in oncology made this past year.

Key opinion leaders share some of the biggest advancements in oncology in 2017.

Related Videos

Brian A. Van Tine, MD, PhD

Jason Luke, MD, FACP

Katherine B. Peters, MD, PhD

Yasushi Goto, MD

Prithviraj Bose, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Jun Ma, MD

Hussein A. Tawbi, MD, PhD

Katsumori Asai, MD, PhD

Bernard Doger de Spéville, MD, PhD

Related Content

Talazoparib Plus Enzalutamide Has Manageble Toxicity With Dose Modifications, Supportive Care in mCRPC

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

August 6th 2020

Updates and Advances in Early Stage Breast Cancer

Integrating Nutrition Into the Continuum of Cancer Care

Forging a New Field

November 25th 2022

FDA Greenlights Leuprolide Acetate Injection for Palliative Treatment in Advanced Prostate Cancer

November 2nd 2022

Talazoparib Plus Enzalutamide Has Manageble Toxicity With Dose Modifications, Supportive Care in mCRPC

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

August 6th 2020

Updates and Advances in Early Stage Breast Cancer

Integrating Nutrition Into the Continuum of Cancer Care

Forging a New Field

November 25th 2022

FDA Greenlights Leuprolide Acetate Injection for Palliative Treatment in Advanced Prostate Cancer

November 2nd 2022

Talazoparib Plus Enzalutamide Has Manageble Toxicity With Dose Modifications, Supportive Care in mCRPC

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

August 6th 2020

Updates and Advances in Early Stage Breast Cancer

Integrating Nutrition Into the Continuum of Cancer Care

Forging a New Field

November 25th 2022

FDA Greenlights Leuprolide Acetate Injection for Palliative Treatment in Advanced Prostate Cancer

November 2nd 2022

Related Content

Arun Azad, MBBS, PhD, FRACP

Talazoparib Plus Enzalutamide Has Manageble Toxicity With Dose Modifications, Supportive Care in mCRPC

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

August 6th 2020

Updates and Advances in Early Stage Breast Cancer

Updates and Advances in Early Stage Breast Cancer

Integrating Nutrition Into the Continuum of Cancer Care

Integrating Nutrition Into the Continuum of Cancer Care

Jennifer Temel, MD, clinical Director of Thoracic Oncology, co-Director, Cancer Outcomes Research and Education Program, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School.

Forging a New Field

November 25th 2022

The FDA has approved leuprolide acetate injection for use in the palliative treatment of patients with advanced prostate cancer.

FDA Greenlights Leuprolide Acetate Injection for Palliative Treatment in Advanced Prostate Cancer

November 2nd 2022

Latest Conference Coverage

Epcoritamab Plus Rituximab/Lenalidomide Produces Responses in High-risk R/R Follicular Lymphoma

TTFields Plus SOC Improves OS in Metastatic NSCLC After Progression on Platinum-based Chemotherapy

Liso-Cel Leads to Rapid Responses, High Undetectable MRD Rates in Relapsed/Refractory CLL/SLL

Datopotamab Deruxtecan Plus Pembrolizumab With or Without Chemo Produces Responses in Advanced NSCLC

View More Latest Conference Coverage

Editorial Board

CancerNetwork.com

OncNursingNews.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.